Compare Humana Inc (HUM) vs iShares Core MSCI Emerging Markets ETF (IEMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs iShares Core MSCI Emerging Markets ETF — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while iShares Core MSCI Emerging Markets ETF trades at $79.85. The key difference: Humana Inc pays a 0.92% dividend while iShares Core MSCI Emerging Markets ETF pays none, and Humana Inc is trading nearer its 52-week high, iShares Core MSCI Emerging Markets ETF nearer its low. Which is the better fit depends on your goals.
| HUM | IEMG | |
|---|---|---|
Market Cap | $46.31B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $409.42 | $86.00 |
52-Week Low | $163.67 | $61.76 |
Enterprise Value | $53.67B | — |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
IEMG trades at $79.99, up 0.81% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF focuses on emerging markets with a 0.09% expense ratio and a 40% technology weighting, driven by AI-related stocks in South Korea and Taiwan. Recent news highlights strong inflows and outperformance versus U.S. benchmarks, though volatility remains elevated.
Outlook is positive due to attractive valuations and growth in emerging markets, but risks include concentration in tech, geopolitical tensions, and higher volatility. Analysts note potential for gains but advise caution after a 39% surge over the past year.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About iShares Core MSCI Emerging Markets ETF
IEMG tracks the MSCI Emerging Markets Investable Market Index, providing broad exposure to large, mid, and small-cap stocks across over 20 emerging market countries. It is designed as a low-cost core holding for investors seeking diversified growth from economies outside of developed markets.
Read more on IEMG →
